Studies on the mechanism of cytoplasmic antigen accumulation following infection with a new variant of polyoma virus.
D000818:Animals; D000941:Antigens / Q000378:metabolism*; D000956:Antigens, Viral / Q000378:metabolism; D001120:Arginine / Q000378:metabolism; D002172:Canavanine / Q000494:pharmacology; D002467:Cell Nucleus / Q000276:immunology; D002478:Cells, Cultured / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D003080:Cold Temperature; D003513:Cycloheximide / Q000494:pharmacology; D003593:Cytoplasm / Q000276:immunology*; D004279:DNA, Viral / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology; D005467:Floxuridine / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D014644:Genetic Variation; D005827:Genetics, Microbial; D007106:Immune Sera / Q000494:pharmacology; D051379:Mice; D008854:Microscopy, Electron; D011120:Polyomavirus / Q000254:growth & development / Q000276:immunology* / Q000378:metabolism; D013997:Time Factors; D014764:Viral Proteins / Q000378:metabolism*; D014779:Virus Replication
D000941:Antigens; D000956:Antigens, Viral; D004279:DNA, Viral; D007106:Immune Sera; D014764:Viral Proteins; D005467:Floxuridine; D003609:Dactinomycin; D002172:Canavanine; D001120:Arginine; D003513:Cycloheximide